Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lalita Savardekar is active.

Publication


Featured researches published by Lalita Savardekar.


British Journal of Obstetrics and Gynaecology | 2010

Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial

H. von Hertzen; N. T. M. Huong; Gilda Piaggio; M. Bayalag; Evelio Cabezas; A. H. Fang; Kristina Gemzell-Danielsson; N. D. Hinh; Suneeta Mittal; Ernest Hung Yu Ng; K. Chaturachinda; B. Pinter; L. Puscasiu; Lalita Savardekar; S. Shenoy; A. Khomassuridge; Hoang Thi Diem Tuyet; A. Velasco; Alexandre Peregoudov

Please cite this paper as: von Hertzen H, Huong N, Piaggio G, Bayalag M, Cabezas E, Fang A, Gemzell‐Danielsson K, Hinh N, Mittal S, Ng E, Chaturachinda K, Pinter B, Puscasiu L, Savardekar L, Shenoy S, Khomassuridge A, Tuyet H, Velasco A, Peregoudov A, for the WHO Research Group on Postovulatory Methods of Fertility Regulation. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial. BJOG 2010;117:1186–1196.


Fertility and Sterility | 2009

Protein profiling of human endometrial tissues in the midsecretory and proliferative phases of the menstrual cycle

Tanu Parmar; Sushama Gadkar-Sable; Lalita Savardekar; R.R. Katkam; Shalmali J. Dharma; Pervin Meherji; Chander Parkash Puri; Geetanjali Sachdeva

OBJECTIVE To identify the proteins displaying differential expression in midsecretory phase endometrium as compared with proliferative phase endometrium. DESIGN Prospective study with two groups of women in the midsecretory or proliferative phase. SETTING Clinical research outpatient department. PATIENT(S) Healthy, regularly cycling women of proven fertility. INTERVENTION(S) Collection of endometrial biopsy samples. MAIN OUTCOME MEASURE(S) Image analysis software was used to compare two-dimensional protein maps of midsecretory phase endometrial tissues (MSE) with maps of proliferative phase endometrial tissues (PROE) and midsecretory phase uterine fluids (MSU). Matrix-assisted laser desorption/ionization time of flight in tandem (MALDI-TOF-TOF) analysis was carried out to identify eight proteins that were differentially expressed between the two phases and also to identify the spots that shared similar coordinates in the two-dimensional maps of MSE and MSU. RESULT(S) Densitometry analysis and subsequent MALDI-TOF-TOF analysis revealed up-regulation of calreticulin, the beta chain of fibrinogen, adenylate kinase isoenzyme 5, and transferrin in the PROE and of annexin V, alpha1-antitrypsin, creatine kinase, and peroxidoxin 6 in MSE compared with the other phase. Superimposition of the two-dimensional maps of MSE on those of MSU revealed the presence of heat-shock protein 27, transferrin, and alpha1-antitrypsin precursor in both endometrial tissues and uterine secretions. CONCLUSION(S) Differentially expressed proteins identified in the present study could be of relevance in endowing the endometrium with receptivity.


Gynecological Endocrinology | 2010

Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes

Madhavi Pusalkar; Pervin Meherji; Jyotsna Gokral; Lalita Savardekar; Saravanan Chinnaraj; Anurupa Maitra

Obesity and hyperandrogenaemia are key features of polycystic ovary syndrome (PCOS). The aim of this study was to investigate whether leptin and androgens are associated with obesity in PCOS subjects and identify whether there exist any genetic alterations in leptin gene in women with PCOS. The results reveal that leptin levels are elevated in women with PCOS and associate with BMI. However, irrespective of the obesity status leptin levels are higher in PCOS cases indicating that increased BMI/obesity may not be the only factor contributing to elevated levels of leptin. With regard to testosterone and androstenedione, the levels were increased in obese individuals irrespective of PCOS status. No correlation between leptin and androstenedione or testosterone was observed in controls and PCOS subjects. The single-nucleotide polymorphism G19A detected in the untranslated exon 1 of leptin gene was not associated with PCOS and does not contribute to elevated levels of leptin. The results overall suggest that androgen and leptin levels are increased in PCOS and obesity. It demonstrates that obesity is a confounding factor for hyperandrogenaemia irrespective of their PCOS status. The study rules out role of obesity status and leptin genotype in increase in leptin levels observed in PCOS cases.


Human Reproduction | 2014

High mobility group box 1 (HMGB1) protein in human uterine fluid and its relevance in implantation

Sumit Bhutada; T. Basak; Lalita Savardekar; R.R. Katkam; Gauri Jadhav; S.M. Metkari; Uddhav Chaudhari; Divya Kumari; Sanjiva D. Kholkute; S. Sengupta; Geetanjali Sachdeva

STUDY QUESTION Does a differential abundance of high mobility group box 1 (HMGB1) protein in uterine fluid (UF) have a functional significance? SUMMARY ANSWER In rats, an excess of HMGB1 in UF during the receptive phase is detrimental to pregnancy. WHAT IS KNOWN ALREADY The identification of constituents of the human uterine secretome has been a subject of renewed interest, due to the advent of high throughput proteomic technologies. Proteomic-based investigations of human UF have revealed the presence of several proteins such as mucins, host defense proteins S100, heat shock protein 27 and haptoglobin, etc. The present study reports on the presence of HMGB1, a nuclear protein, in human UF. Activated macrophages/monocytes, natural killer cells, mature dendritic cells, pituicytes and erythroleukemic cells are also known to secrete HMGB1. Existing data suggest that extracellular HMGB1 plays a role in inflammation. STUDY DESIGN, SIZE, DURATION The human part of this study was cross-sectional in design. UF and endometrial tissues were collected from regularly cycling women in the early secretory (i.e. pre-receptive phase, Day 2 post-ovulation, n = 7) or secretory phase (i.e. receptive phase, Day 6 post-ovulation, n = 7) of their menstrual cycles. Samples were also collected from cycling rats in the proestrous (n = 8) or metestrous (n = 8) phase of their estrous cycles. Uteri were also collected from HMGB1-treated pregnant (n = 7) and untreated pseudo-pregnant (n = 7) rats and from pregnant rats at Day 3-5 post-coitum (p.c.) (n = 18, 3 each for six-time points). PARTICIPANTS/MATERIALS, SETTING, METHODS In each group of human samples, four samples were used for isobaric tag for relative and absolute quantification (iTRAQ) analysis and three samples were used for immunoblotting experiments to determine the abundance of HMGB1 in pre-receptive and receptive phase UF samples. HMGB1 levels in rat UF and endometrial tissue samples were estimated by ELISA and immunohistochemical studies, respectively. The expression of inflammation-associated molecules, such as nuclear factor kappa B (NFκB), receptor for advanced glycation end products (RAGEs), tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6), was analyzed by immunohistochemistry in HMGB1-treated and pseudo-pregnant rats. MAIN RESULTS AND THE ROLE OF CHANCE HMGB1 was identified as one of the differentially abundant proteins in the list generated by 8-plex iTRAQ analysis of receptive and pre-receptive phase UF samples. In both humans and rats, secreted and cellular levels of HMGB1 showed a similar pattern, i.e. significantly (P < 0.05) lower abundance in the receptive phase compared with that in the pre-receptive phase. A significant (P < 0.05) decline was also observed in the endometrial expression of HMGB1 on the day of implantation in pregnant rats. Exogenous administration of recombinant HMGB1, on Day 3 p.c., led to pregnancy failure, whereas administration of recombinant leukemia inhibitory factor or saline had no effect on pregnant rats. Further investigations revealed morphological changes in the endometrium, an increase in the expression of luminal epithelial NFκB and significantly (P < 0.05) higher expression levels of endometrial RAGE, TNF-α and IL-6 in HMGB1-treated rats, compared with untreated pseudo-pregnant rats. LIMITATIONS, REASONS FOR CAUTION The mechanisms, contributing to a decline in the cellular and extracellular levels of HMGB1 during the receptive phase, remain to be ascertained. WIDER IMPLICATIONS OF THE FINDINGS An excess of HMGB1 in the UF may be associated with infertility in women.


American Journal of Reproductive Immunology | 2016

Secrets of Endometrial Receptivity: Some Are Hidden in Uterine Secretome

Kashmira Bhusane; Sumit Bhutada; Uddhav Chaudhari; Lalita Savardekar; R.R. Katkam; Geetanjali Sachdeva

Endometrium, the innermost mucosal layer of the uterus, serves as a lodge for the embryo in eutherian mammals. The endometrium is constituted of various cell types, and each cell type executes specific functions to facilitate embryo implantation and development. It is well established that the endometrium, despite being non‐permissive to the embryo for the major period of a menstrual cycle, is irreplaceable in the scheme of events essential for procreation. However, the embryo, before initiating physical contact with the endometrium, encounters the uterine cavity that remains bathed in uterine fluid. Uterine fluid is an admixture of endometrial secretions, plasma transudates, and oviductal fluid. Uterine fluid components are believed to play important roles in immunosuppression and embryo development during peri‐implantation period. Uterine fluid is also involved in defense against pathogens, sperm migration, and lubrication of endometrium. The advent of high‐throughput functional genomics tools has created enormous opportunities to investigate the uterine fluid for its protein repertoire and modulation during the receptive phase of an endometrial cycle in animals and humans. Towards this, few investigations have been conducted in recent years. The data obtained using non‐targetted functional genomics approaches need to be assimilated with the existing information on specific components of uterine fluid.


Acta Cytologica | 2010

Association of Schistosoma haematobium and Human Papillomavirus in Cervical Cancer

Lalita Savardekar; Donta Balaiah; Mali Bn

BACKGROUND The association between Schistosoma haematobium and cervical cancer has been reported for a long time. However, recently human papillomavirus, a cofactor in the genesis of cervical cancer, has been confirmed. A case of squamous intraepithelial lesion after S haematobium infection is presented, and the relation between schistosomiasis, human papillomavirus and squamous intraepithelial lesion, with long-term follow-up by Papanicolaou smear, is discussed. CASE A 33-year-old, normal, healthy woman with a history of Copper intrauterine device (IUD) use for 3.9 years presented for her annual contraceptive follow-up. Her Pap smear revealed inflammation with a S haematobium egg. She was followed up with Pap smears for 4 years. Retrospective contraceptive history revealed use ofa copper IUD on 5 occasions with a total duration of 13 years and 1 month. Similarly, annual follow-up of Pap smears for the past 13 years showed mild inflammation with bacterial vaginitis and monilial infection. Subsequent smears showed an Actinomyces-like organism and then human papillomavirus infection with atypical squamous cells of undetermined significance followed by human papillomavirus-associated low/high grade squamous intraepithelial lesion. CONCLUSION Caution is required while screening routine Pap smears. Apart from nuclear abnormalities, one can observe unusual findings. Long-term followup by Pap smear following detection of S haematobium revealed that in the absence of human papillomavirus, S haematobium alone is not the causative agent for the abnormal proliferation of squamous epithelium of the cervix. Genital Schistosomia acts as a cofactor by traumatizing the genital epithelium or immune suppression to favor human papillomavirus infection.


Malaria Research and Treatment | 2013

Clinical Manifestations, Treatment, and Outcome of Hospitalized Patients with Plasmodium vivax Malaria in Two Indian States: A Retrospective Study

Jagjit Singh; Bhargav Purohit; Anupama Desai; Lalita Savardekar; Preeti Shanbag; Nilima Kshirsagar

This was a retrospective study done on 110 patients hospitalized with P. vivax malaria in three medical college hospitals, one in the union territory of Chandigarh and the other two in Gujarat, that is, Ahmedabad and Surat. The clinical presentation, treatment, and outcome were recorded. As per WHO criteria for severity, 19 of 110 patients had severe disease—six patients had clinical jaundice with hepatic dysfunction, three patients had severe anemia, three had spontaneous bleeding, two had acute respiratory distress syndrome, and one had cerebral malaria, hyperparasitemia, renal failure, circulatory collapse, and metabolic acidosis. All patients with severe P. vivax malaria survived, but one child with cerebral malaria had neurological sequelae. There was wide variation in the antimalarial treatment received at the three centres. Plasmodium vivax malaria can no longer be considered a benign condition. WHO guidelines for treatment of P. vivax malaria need to be reinforced.


Human Reproduction | 2009

Differential expression of calreticulin, a reticuloplasmin in primate endometrium

T. Parmar; Shruti Nimbkar-Joshi; R.R. Katkam; S. Gadkar-Sable; Uddhav Chaudhari; Dhananjay D. Manjramkar; Lalita Savardekar; Sheeba Jacob; Chander Parkash Puri; Geetanjali Sachdeva

BACKGROUND To our knowledge, there are no data on hormonal regulation of reticuloplasmins in primate endometrium. We report the presence and modulation of expression of three reticuloplasmins in endometrium of bonnet monkeys (Macaca radiata). METHODS Receptive and non-receptive endometria obtained from vehicle-treated control and onapristone (antiprogestin)-treated animals, respectively, were compared for differentially expressed proteins by two-dimensional proteomics. Mass spectrometric analysis annotated two such proteins as calreticulin and protein disulfide-isomerase (PDI), known to be molecular chaperones in endoplasmic reticulum. We then investigated if endoplasmin, another reticuloplasmin is also differentially expressed. Expression of these reticuloplasmins was also investigated in the endometriuma during pregnancy in bonnet monkeys. Samples were analysed by immunohistochemistry and western blot (calreticulin in human endometrium), and calreticulin transcript levels in Ishikawa cell line were assessed by real time PCR. RESULTS Immunohistochemical analysis of the functionalis region of non-receptive endometria in monkeys revealed higher expression of (i) calreticulin (P < 0.01) in glandular epithelium and (ii) PDI in stroma (P < 0.0001), but no change in endoplasmin in stroma or glands, compared with receptive endometria. Protein level of all three reticuloplasmins in the stromal region of endometrial functionalis was higher in pregnant than non-pregnant animals (P < 0.05). Human endometrial calreticulin protein was higher in the estrogen-dominant (proliferative) phase than progesterone-dominant (mid-secretory) phase of the cycle. Calreticulin mRNA in Ishikawa cells is up-regulated by estrogen (P < 0.05 versus control), with a trend towards down-regulation by progesterone. CONCLUSION Our data suggest that endometrial reticuloplasmins are regulated by hormones and embryonic stimuli in a cell-type specific manner. These novel data open up new lines of investigation for elucidating the mechanisms by which hormones or embryonic stimuli influence the sub-cellular physiology of endometrium.


Human Reproduction | 2007

Protein repertoire of human uterine fluid duringthe mid-secretory phase of the menstrual cycle

T. Parmar; Geetanjali Sachdeva; Lalita Savardekar; R.R. Katkam; Shruti Nimbkar-Joshi; S. Gadkar-Sable; V. Salvi; Dhananjay D. Manjramkar; Pervin Meherji; Chander Parkash Puri


Osteoporosis International | 2007

Hormonal profiles and biochemical indices of bone turnover in Indian women.

P. Desai Meena; M. I. Khatkhatay; K. V. Bhanu Prakash; Lalita Savardekar; Rashmi Shah; Z. Ansari

Collaboration


Dive into the Lalita Savardekar's collaboration.

Top Co-Authors

Avatar

Geetanjali Sachdeva

National Institute for Research in Reproductive Health

View shared research outputs
Top Co-Authors

Avatar

R.R. Katkam

National Institute for Research in Reproductive Health

View shared research outputs
Top Co-Authors

Avatar

Chander Parkash Puri

National Institute for Research in Reproductive Health

View shared research outputs
Top Co-Authors

Avatar

Dhananjay D. Manjramkar

National Institute for Research in Reproductive Health

View shared research outputs
Top Co-Authors

Avatar

Pervin Meherji

National Institute for Research in Reproductive Health

View shared research outputs
Top Co-Authors

Avatar

Rashmi Shah

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Uddhav Chaudhari

National Institute for Research in Reproductive Health

View shared research outputs
Top Co-Authors

Avatar

Mali Bn

National Institute for Research in Reproductive Health

View shared research outputs
Top Co-Authors

Avatar

S. Gadkar-Sable

National Institute for Research in Reproductive Health

View shared research outputs
Top Co-Authors

Avatar

Shruti Nimbkar-Joshi

National Institute for Research in Reproductive Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge